𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic interest of bone turnover markers in the management of postmenopausal osteoporosis

✍ Scribed by Florence Chopin; Emmanuel Biver; Thomas Funck-Brentano; Béatrice Bouvard; Guillaume Coiffier; Patrick Garnero; Thierry Thomas

Book ID
113685112
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
200 KB
Volume
79
Category
Article
ISSN
1297-319X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of denosumab on bone turnover ma
Effects of denosumab on bone turnover markers in postmenopausal osteoporosis
✍ Richard Eastell; Claus Christiansen; Andreas Grauer; Stepan Kutilek; Cesar Liban 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 272 KB 👁 1 views

## Abstract Denosumab, a fully human monoclonal antibody to RANKL, decreases bone remodeling, increases bone density, and reduces fracture risk. This study evaluates the time course and determinants of bone turnover marker (BTM) response during denosumab treatment, the percentage of denosumab‐treat